New Dystonia Research Reported from University of Rosario (Botulinum Toxin Type B vs Type A in Cervical Dystonia: A Meta - analysis of high quality trials).

A recent study conducted at the University of Rosario compared the efficacy of Botulinum Toxin (BT) type B versus type A and placebo in patients with cervical dystonia (CD). The study found that BT type B was effective in improving TWSTRS scores at 4 weeks compared to placebo. However, there was no significant difference in efficacy between BT type B and type A. Adverse events such as dry mouth and dysphagia were more frequent in the BT type B group. The researchers concluded that further studies are needed to evaluate therapeutic options for patients resistant to BT type A. [Extracted from the article]

Copyright of Drug Week is the property of NewsRx and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)